Healthcare Equipment and Supplies
Company Overview of MicroPort Scientific Corporation
MicroPort Scientific Corporation, an investment holding company, develops, manufactures, and sells interventional medical devices worldwide. Its Orthopedics Devices segment offers reconstructive joints, spine, trauma, sports medicine, and other professional implants and equipment. The company’s Cardiovascular Devices segment provides coronary stents and related delivery systems; and dilatation catheters and accessories. Its Endovascular Devices segment provides a range of products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company’s Electrophysiological ...
1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Founded in 1998
Key Executives for MicroPort Scientific Corporation
Founder, Chairman, Chief Executive Officer and Member of Remuneration Committee
Total Annual Compensation: $60.0K
Compensation as of Fiscal Year 2015.
MicroPort Scientific Corporation Key Developments
MicroPort Scientific Corporation Provides Earnings Guidance for the Year Ended December 31, 2016
Feb 5 17
MicroPort Scientific Corporation provided earnings guidance for the year ended December 31, 2016. For the year, the company expects to record a net profit of not less than USD 10 million as compared with a net loss of USD 11.38 million for the corresponding period in 2015. The expected increase in the unaudited net profit for the year ended December 31, 2016 is principally attributable to: a significant growth in revenue from the cardiovascular and endovascular segments in the PRC market, and in particular, a significant revenue growth of its third generation coronary stent product Firehawk Drug Eluting Stent; a substantial reduction of net loss of the OrthoRecon business due to the improvement in gross margin and the decrease in operating expenses through execution of cost saving initiatives; and increase in government grants and foreign exchange gain from its RMB-denominated debts of overseas subsidiaries resulting from the depreciation of RMB.
MicroPort Scientific Corporation - Shareholder/Analyst Call
Dec 21 16
To discuss strategic investment and partnership with Lombard
Lombard Medical, Inc. and MicroPort Scientific Corporation Announce Strategic Partnership
Dec 19 16
Lombard Medical, Inc. and MicroPort Scientific Corporation announced strategic partnership and significant infusion of capital into Lombard Medical by MicroPort. This partnership will allow Lombard Medical to accelerate commercialization in key global markets with its two key products: Aorfix™, the only stent graft to hold global approvals to treat abdominal aortic aneurysms with aortic neck angles up to 90 degrees, and Altura, a highly innovative stent graft that offers a simple and predictable treatment option for standard AAA anatomy. The agreement provides MicroPort the exclusive marketing rights for Lombard Medical’s Aorfix and Altura AAA stent graft product lines in China, as well as the right to a technology license to manufacture the products for the China market. Lombard Medical and MicroPort will also enter into component supply manufacturing agreement whereby MicroPort will manufacture in its facilities in Shanghai certain components for the Aorfix and Altura product lines. MicroPort will also have exclusive marketing rights for both Altura and Aorfix in Brazil.
Similar Private Companies By Industry
Recent Private Companies Transactions
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries